Mirabegron

Product NDC
73190-115
11-digit product format
731900115
Labeler code
73190
Product ID
73190-115_5f102149-ad28-4956-e063-6294a90ac6ad
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Mirabegron
Dosage form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Labeler
AvKARE
Application
ANDA218543
Marketing category
ANDA
Marketing start
2026-10-30
Substance
MIRABEGRON
Active strength
25 mg/1
Pharmacologic classes
Adrenergic beta3-Agonists [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], beta3-Adrenergic Agonist [EPC]
NDC exclude flag
No
Listing certified through
2027-12-31
Current FDA listing
Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 45.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A218543-001MIRABEGRONMIRABEGRON25MGTABLET, EXTENDED RELEASE / ORALAB2025-11-04
A218543-002MIRABEGRONMIRABEGRON50MGTABLET, EXTENDED RELEASE / ORALAB2025-11-04

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 2 matching rows.

Application-product, TE code table
Application-productTE code
A218543-001AB
A218543-002AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-11-14 07:37:172026-10A218543-001MIRABEGRON25MGTABLET, EXTENDED RELEASE / ORALAB2025-11-04d4dbc9d85df4…
2026-11-14 07:37:172026-10A218543-002MIRABEGRON50MGTABLET, EXTENDED RELEASE / ORALAB2025-11-04d4dbc9d85df4…
2026-10-15 13:18:302026-09A218543-001MIRABEGRON25MGTABLET, EXTENDED RELEASE / ORALAB2025-11-04c2088c7a36db…
2026-10-15 13:18:302026-09A218543-002MIRABEGRON50MGTABLET, EXTENDED RELEASE / ORALAB2025-11-04c2088c7a36db…
2026-09-14 22:38:342026-08A218543-001MIRABEGRON25MGTABLET, EXTENDED RELEASE / ORALAB2025-11-0484e616aacf4f…
2026-09-14 22:38:342026-08A218543-002MIRABEGRON50MGTABLET, EXTENDED RELEASE / ORALAB2025-11-0484e616aacf4f…
2026-08-18 06:07:402026-07A218543-001MIRABEGRON25MGTABLET, EXTENDED RELEASE / ORALAB2025-11-04caaa826d4ba7…
2026-08-18 06:07:402026-07A218543-002MIRABEGRON50MGTABLET, EXTENDED RELEASE / ORALAB2025-11-04caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A218543-001MIRABEGRON25MGTABLET, EXTENDED RELEASE / ORALAB2025-11-04011fe1cb6892…
2026-02-19 14:30 UTC2026-02A218543-002MIRABEGRON50MGTABLET, EXTENDED RELEASE / ORALAB2025-11-04011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A218543-001MIRABEGRON25MGTABLET, EXTENDED RELEASE / ORALAB2025-11-0431067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A218543-002MIRABEGRON50MGTABLET, EXTENDED RELEASE / ORALAB2025-11-0431067a03dcf5…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A218543-001MIRABEGRON25MGTABLET, EXTENDED RELEASE / ORALAB2025-11-04a50c72e98297…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A218543-002MIRABEGRON50MGTABLET, EXTENDED RELEASE / ORALAB2025-11-04a50c72e98297…

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-11-14 07:37:172026-10A218543-001AB1d4dbc9d85df4…
2026-11-14 07:37:172026-10A218543-002AB1d4dbc9d85df4…
2026-10-15 13:18:302026-09A218543-001AB1c2088c7a36db…
2026-10-15 13:18:302026-09A218543-002AB1c2088c7a36db…
2026-09-14 22:38:342026-08A218543-001AB184e616aacf4f…
2026-09-14 22:38:342026-08A218543-002AB184e616aacf4f…
2026-08-18 06:07:402026-07A218543-001AB1caaa826d4ba7…
2026-08-18 06:07:402026-07A218543-002AB1caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A218543-001AB1011fe1cb6892…
2026-02-19 14:30 UTC2026-02A218543-002AB1011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A218543-001AB131067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A218543-002AB131067a03dcf5…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A218543-001AB1a50c72e98297…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A218543-002AB1a50c72e98297…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product
Yes
Brand name base
Mirabegron
Listing expiration
2027-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
MIRABEGRON25 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
MVR3JL3B2VInternal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 2 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
1300791Internal RxNorm lookup
1300801Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
5f102149-ad27-4956-e063-6294a90ac6adAvailable on FDA.report

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
MirabegronMIRABEGRONAvKARE5f102149-ad27-4956-e063-6294a90ac6ad2026-10-30Warnings, Adverse reactionsExact identifier
application applno (ANDA): 218543
application number: ANDA218543
ndc (product): 73190-115
MirabegronMIRABEGRONAmneal Pharmaceuticals NY LLCe597023d-6dcc-4d9e-8ce0-2d28a5d862f32026-03-26Warnings, Adverse reactionsExact identifier
application applno (ANDA): 218543
application number: ANDA218543

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startSampleExclude flagStatus
73190-115-307319001153030 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (73190-115-30) 2026-10-30NoNoCurrent
73190-115-907319001159090 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (73190-115-90) 2026-10-30NoNoCurrent